This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tomocube, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Young Seo Kim: Pioneering Innovations in Hematologic Malignancy Diagnosis
Introduction
Young Seo Kim, hailing from Daejeon, South Korea, is an accomplished inventor whose work is making significant strides in the medical field, specifically in the rapid diagnosis of hematologic malignancies. With a patent to his name, Kim’s innovations aim to improve efficiency and accuracy in cancer detection, utilizing advanced technologies.
Latest Patents
Kim holds a patent for a groundbreaking invention titled "Method and apparatus for rapid diagnosis of hematologic malignancy using 3D quantitative phase imaging and deep learning." This invention features a non-label diagnosis apparatus that comprises several key components. It utilizes a 3-D refractive index cell imaging unit that generates a 3-D refractive index slide image of a blood smear specimen. This imaging is critical in detecting potential malignancies in blood, including components sourced from bone marrow or other bodily fluids.
The apparatus incorporates an ROI detection unit that samples suspected cell segments based on the 3-D images, effectively identifying abnormal cells. It is equipped with a diagnosis unit that leverages a deep learning algorithm to classify cancer cells, providing refined diagnostic results by compiling sub-classification outputs of the selected regions of interest.
Career Highlights
Currently, Young Seo Kim works at Tomocube, Inc., where he contributes to advancements in medical imaging and diagnostics. His innovative approach has positioned him among prominent figures in the field, demonstrating a commitment to enhancing diagnostic methodologies.
Collaborations
In his professional journey, Kim collaborates with talented individuals such as YongKeun Park and Donghun Ryu. Together, they represent a mix of expertise and innovation that propels their projects forward, aiming for breakthroughs in hematologic malignancy diagnosis.
Conclusion
Young Seo Kim’s contributions to the field of hematologic malignancy diagnosis through his inventive methods and teamwork reflect the vital role of innovation in healthcare. His patented technologies promise to pave the way for more rapid and accurate cancer diagnostics, inspiring further advancements in medical technology. As his career progresses, Kim’s work continues to hold great potential for improving patient outcomes in the realm of cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile